PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical
decision making for patients with locally advanced esophageal cancer. METHODS ASCO …

PURPOSE The optimal neoadjuvant treatment for resectable carcinoma of the thoracic
esophagus (TE) or gastroesophageal junction (GEJ) remains a matter of debate. We …

Simple Summary The five-year survival for resectable proximal gastric, gastroesophageal
junction (GEJ), and distal esophageal cancer ranges from 30 to 60% globally. Neoadjuvant …

Diagnosis and therapy of esophageal carcinoma is challenging and requires a
multidisciplinary approach. The purpose of the updated German guideline “Diagnosis and …

Background Reports have shown that neoadjuvant concurrent chemoradiotherapy (nCRT)
increases the R0 resection rate for patients with Siewert type II or III adenocarcinoma of the …

Alternative pre-mRNA splicing is a key mechanism for increasing proteomic diversity and
modulating gene expression. Emerging evidence indicated that the splicing program is …

Background This is the first meta-analysis to study optimal radiation dose in the setting of
concurrent neoadjuvant chemoradiotherapy (cnCRT) for esophageal cancer (EC). We …

Background and Objectives. Gastric cancer (GC) is one of the common gastrointestinal
tumors and the third in the mortality rate among tumors. Studies have shown that the human …

Objective: To study the effects of preoperative enteral nutrition (EN) on postoperative recent
nutritional status (PRNS) in patients with Siewert II and III adenocarcinomas of …

Background To analyze whether neoadjuvant chemoradiotherapy (nCRT) could improve the
survival for patients with adenocarcinoma of the esophagogastric junction compared with …